Comparison of continuation rates with three TNFα antagonists (adalimumab, infliximab, etanercept) in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: Retrospective 10-year study

2016 ◽  
Vol 83 (5) ◽  
pp. 607-609 ◽  
Author(s):  
Benjamin Batteux ◽  
Agathe Devauchelle ◽  
Pauline Lasselin Boyard ◽  
Alice Sejourné ◽  
Patrice Fardellone ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Psoriatic Arthritis ◽  
Ankylosing Spondylitis ◽  
Continuation Rates

Rheumatology

2020 ◽  
pp. 263-306
Author(s):  
Charlotte Frise ◽  
Sally Collins
Keyword(s):  
Rheumatoid Arthritis ◽  
Systemic Lupus Erythematosus ◽  
Systemic Sclerosis ◽  
Psoriatic Arthritis ◽  
Ankylosing Spondylitis ◽  
Lupus Erythematosus ◽  
Pregnant Patient ◽  
Systemic Lupus ◽  
Musculoskeletal Problems ◽  
In Pregnancy

This chapter covers rheumatic diseases in the pregnant patient. It gives background, clinical features, and management in the pregnant patient for rheumatoid arthritis, Sjögren’s syndrome, psoriatic arthritis, systemic lupus erythematosus, antiphospholipid syndrome, and ankylosing spondylitis among others. It also covers systemic sclerosis, osteoporosis, and other musculoskeletal problems. Medications and the use of biologics in pregnancy are also discussed, with reference to breastfeeding.

scholarly journals Three TNF-A-Inhibitors for Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis

2013 ◽  
Vol 16 (7) ◽  
pp. A564
Author(s):  
O. Ivakhnenko ◽  
O. Rebrova ◽  
M. Avxentyeva ◽  
G. Khachatryan
Keyword(s):  
Rheumatoid Arthritis ◽  
Psoriatic Arthritis ◽  
Ankylosing Spondylitis
Sign in / Sign up

Export Citation Format

Share Document